Retraction: Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway (PLoS One (2013) 8:1 (e55487) DOI: 10.1371/journal.pone.0055487);Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Liu, Wen hua ^a   Liu, Jing jin ^a   Wu, Jian ^a   Zhang, Lu lu ^a   Liu, Fang ^a   Yin, Li ^a   Zhang, Mao mao ^a   Yu, Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; JANUS KINASE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OX62 ANTIGEN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; GROWTH INHIBITION; IMMUNOFLUORESCENCE TEST; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84873874027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194455     Document Type: Erratum

References (35)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymalstem cells. Science 284(5411): 143-147.
2. Szade K, Zuba-Surma E, Rutkowski AJ, Jozkowicz A, Dulak J, (2011) CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture. Mol Cells 31(6): 497-507.
3. Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, et al. (2003) Characterization and functionality of cell surface molecules on human mesenchymal stem cells.J Biomed Sci. 10(2): 228-241.
4. Wang X, Hisha H, Taketani S, Adachi Y, Li Q, et al. (2006) Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 24(3): 482-493.
5. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, et al. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101(9): 3722-3729.
6. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L, (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113(26): 6576-83.
7. Aldinucci A, Rizzetto L, Pieri L, Nosi D, Romagnoli P, et al. (2010) Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation. J Immunol 185(9): 5102-5110.
8. Kronsteiner B, Peterbauer-Scherb A, Grillari-Voglauer R, Redl H, Gabriel C, et al. (2011) Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell Immunol 67(1): 30-38.
9. Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, et al. (2011) Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.Blood. 118(2): 380-389.
10. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, et al. (2008) Mesenchymal stem cells inhibit natural killer cell proliferation, cytotoxicity and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandinE2. Blood 111(3): 1327-1333.
11. Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, et al. (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25(8): 2025-2032.
12. Chen L, Zhang W, Yue H, Han Q, Chen B, et al. (2007) Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev 16(5): 719-731.
13. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
14. Zhou LJ, Tedder TF, (1996) CD14blood monocytes can differentiate into functionally mature CD83dendritic cells. Proc Natl Acad Sci USA 93(6): 2588-2592.
15. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, et al. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154(10): 5071-5079.
16. Zhang B, Liu R, Shi D, Liu X, Chen Y, et al. (2009) Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 113(1): 46-57.
17. Zhao ZG, Xu W, Sun L, You Y, Li F, et al. (2012) Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest 41(2): 183-198.
18. Groux H, Cottrez F, (2003) The complex role of interleukin-10 in autoimmunity. J Autoimmun 20(4): 281-285.
19. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
20. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G, (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 166(7): 4312-4318.
21. Manuzak J, Dillon S, Wilson C, (2012) Differential Interleukin-10 (IL-10) and IL-23 Production by Human Blood Monocytes and Dendritic Cells in Response to Commensal Enteric Bacteria. Clin Vaccine Immunol 19(8): 1207-1217.
22. Kim YH, Wee YM, Choi MY, Lim DG, Kim SC, et al. (2011) IL-10 induced by CD11b+cells and IL-10 activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allograft. Mol Med 17(7-8): 697-708.
23. Conzelmann M, Wagner AH, Hildebrandt A, Rodionova E, Hess M, et al. (2010) IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochem Pharmacol. 80(12): 2074-2086.
24. Murray PJ, (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178(5): 2623-2629.
25. Nefedova Y, Gabrilovich DI, (2007) Targeting of JAK/STAT pathway in antigen presenting cells in cancer. Curr Cancer Drug Targets 7(1): 71-77.
26. Hirata N, Yanagawa Y, Iwabuchi K, Onoé K, (2009) Selective regulation of interleukin-10 production via Janus kinase pathway in murine conventional dendritic cells. Cell Immunol 258(1): 9-17.
27. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103(12): 4619-4621.
28. Ren G, Su J, Zhao X, Zhang L, Zhang J, et al. (2008) Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide.J Immunol. 181(5): 3277-3284.
29. Zhang M, Liu F, Jia H, Zhang Q, Yin L, et al. (2011) Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1. J Immunol 187(4): 1674-1683.
30. Bishopric NH (2008) Mesenchymal stem cell derived IL-10 and recovery from infarction: a third pitch for the chord.Circ. Res 103;125-127.
31. Li YP, Paczesny S, Lauret E, Poirault S, Bordigoni P, et al. (2008) Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180(3): 1598-608.
32. Posselt G, Schwarz H, Duschl A, Horejs-Hoeck J, (2011) Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol 187(6): 2875-2884.
33. Lee EB, Kim A, Kang K, Kim H, Lim JS, (2010) NDRG2-mediated modulation of SOCS3 and STAT3 activity inhibits IL-10 production. Immune Netw 10(6): 219-229.
34. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haplo identical mesenchymal stem cells. Lancet 363(9149): 1439-1441.
35. Li H, Guo Z, Jiang X, Zhu H, Li X, et al. (2008) Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 26(10): 2531-2541.